Genexine Inc. is engaged in research and development of biotechnology. The company offers innovative immunotherapeutics and next generation novel long acting biologics.Genexine Inc technologies offers HYFC platform which produces long acting Fc fusion proteins by hybriding lgD and lgG4; and Immunotherapy which includes Therapeutic DNA Vaccine Technology as well as Immune Enchancing Technology. Genexine Inc. focuses on three key therapeutics areas: orphans, cancers and immune disorders. The company was formerly known as Genexine Co., Ltd.Genexine Inc. was incorporated in 1999 and is based Seongnam ,South Korea.
Headquarters
4F, B Dong, Korea Bio Park, 700, Daewangpangyo-Ro, Bundang-Gu, Seongnam-Si
Seongnam; Gyeonggi;
Contact Details: Purchase the Genexine Inc. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service